Matches in Nanopublications for { ?s ?p "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion description "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.
- NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_assertion description "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134478.RAmFjj-t2hNpcW3xhh1x4POVA3P__bD1Ww2BwwRoMsr4Q130_provenance.